Skip to content
Tuesday, September 26, 2023
Latest:
  • Orano Med Partners with Biosynth to Develop New Targeting Vector for Radioligand Therapies
  • PeptiDream and Genentech Ink $1 Billion Deal for Peptide-RI Drug Conjugates
  • Stat6 (Phospho-Tyr641) Antibody
  • High Yield Adjuvant for Monoclonal Antibody Production
  • AstraZeneca’s Fasenra Achieves Primary Objective in Phase III Trial in EGPA

Pharma Industry Review

Pharma Industry Review

  • Products
  • Companies
    • Find Suppliers
    • Press Releases
    • Downloads
    • Sponsored
    • Videos
  • Resources
  • Sectors
    • Preclinical Studies
    • Drug Discovery
    • Drug Development
    • Clinical Trials
    • Diagnostics
    • Manufacturing
    • Supply Chain
    • Regulatory
  • RESEARCH AREAS
    • Oncology
    • Immunology
    • Infectious Diseases
      • COVID-19
    • Neurology
    • Respiratory
    • Fibrotic Diseases
    • Renal Diseases
    • Inflammatory Diseases
    • Vascular Diseases
  • Investment
    • Stocks
    • Deals
  • Projects
  • Digitalization
decorative
Deals DISEASES Featured Immunology Inflammatory Diseases 

Sandoz Strengthens Immunology Portfolio with Samsung Bioepis Deal to Commercialize Biosimilar Ustekinumab

September 11, 2023September 11, 2023 Pharmaceutical Industry Editor
Develop New Targeting Vector for Radioligand Therapies
DISEASES Drug Discovery Latest Oncology 

Orano Med Partners with Biosynth to Develop New Targeting Vector for Radioligand Therapies

September 23, 2023September 24, 2023 Pharmaceutical Industry Editor
decorative
Deals Latest 

PeptiDream and Genentech Ink $1 Billion Deal for Peptide-RI Drug Conjugates

September 21, 2023September 21, 2023 Pharmaceutical Industry Editor
decorative
COVID-19 Infectious Diseases Latest Regulatory 

Pfizer and BioNTech Granted Favorable CHMP Assessment for Omicron XBB.1.5-adapted COVID-19 Vaccine in the EU

September 11, 2023September 17, 2023 Pharmaceutical Industry Editor
FDA Greenlights First-ever Treatment for Demodex Blepharitis
Latest Regulatory 

FDA Greenlights First-ever Treatment for Demodex Blepharitis

July 27, 2023July 27, 2023 Pharmaceutical Industry Editor

FEATURED

Develop New Targeting Vector for Radioligand Therapies
DISEASES Drug Discovery Latest Oncology 

Orano Med Partners with Biosynth to Develop New Targeting Vector for Radioligand Therapies

September 23, 2023September 24, 2023 Pharmaceutical Industry Editor

Orano Med, a clinical-stage biotechnology company that develops the next generation of targeted therapies against cancer using the unique properties

decorative
Deals Latest 

PeptiDream and Genentech Ink $1 Billion Deal for Peptide-RI Drug Conjugates

September 21, 2023September 21, 2023 Pharmaceutical Industry Editor
decorative
COVID-19 Infectious Diseases Latest Regulatory 

Pfizer and BioNTech Granted Favorable CHMP Assessment for Omicron XBB.1.5-adapted COVID-19 Vaccine in the EU

September 11, 2023September 17, 2023 Pharmaceutical Industry Editor
FDA Greenlights First-ever Treatment for Demodex Blepharitis
Latest Regulatory 

FDA Greenlights First-ever Treatment for Demodex Blepharitis

July 27, 2023July 27, 2023 Pharmaceutical Industry Editor
decorative
Drug Development Latest Manufacturing Projects 

Manufacturing Pharmaceuticals In Space

June 21, 2023September 19, 2023 Pharmaceutical Industry Editor

DEALS

decorative
Deals Latest 

PeptiDream and Genentech Ink $1 Billion Deal for Peptide-RI Drug Conjugates

September 21, 2023September 21, 2023 Pharmaceutical Industry Editor

PeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kanagawa, Japan, led by President and CEO Patrick C. Reid, has

decorative
Deals DISEASES Featured Immunology Inflammatory Diseases 

Sandoz Strengthens Immunology Portfolio with Samsung Bioepis Deal to Commercialize Biosimilar Ustekinumab

September 11, 2023September 11, 2023 Pharmaceutical Industry Editor
Biosynth Bolsters Capabilities in Conjugate Vaccines and Bioconjugate Drugs Through Celares Acquisition
Deals 

Biosynth Bolsters Capabilities in Conjugate Vaccines and Bioconjugate Drugs Through Celares Acquisition

August 30, 2023August 30, 2023 Pharmaceutical Industry Editor
Biosynth Expands Peptide Business Through Acquisition of Cambridge Research Biochemicals
Deals 

Biosynth Expands Peptide Business Through Acquisition of Cambridge Research Biochemicals

August 30, 2023August 30, 2023 Pharmaceutical Industry Editor

PRESS RELEASES

Aalto Bio Reagents and Fitzgerald Industries International Rebrand to Biosynth
Press Releases 

Aalto Bio Reagents and Fitzgerald Industries International Rebrand to Biosynth

September 3, 2023September 3, 2023 Pharmaceutical Industry Editor

Biosynth has unified the supply of critical biological materials for pharma and diagnostics through the successful rebranding of Aalto Bio

L.B. Bohle presented its new generation of machines
Press Releases 

L.B. Bohle Nominated for German Design Award

August 30, 2023August 30, 2023 Pharmaceutical Industry Editor
Biosynth to Showcase Innovations at CPhI Worldwide 2023 in Barcelona
Press Releases 

Biosynth to Showcase Innovations at CPhI Worldwide 2023 in Barcelona

August 30, 2023August 30, 2023 Pharmaceutical Industry Editor
Biosynth to Exhibit at the Boulder Peptide Symposium 2023
Press Releases 

Biosynth to Exhibit at the Boulder Peptide Symposium 2023

August 30, 2023August 30, 2023 Pharmaceutical Industry Editor

EDITOR’S PICKS

decorative
Comments & Analysis Manufacturing 

The Crucial Role of Heating Technology in Advancing Medical Devices

June 29, 2023June 29, 2023 Pharmaceutical Industry Editor

The current medical devices market boasts an impressive array of approximately 10,000 diverse types of equipment. Each individual device must

Breaking Free from Commercial Limitations with Custom Chemical Synthesis
Comments & Analysis Drug Development Drug Discovery 

Breaking Free from Commercial Limitations with Custom Chemical Synthesis

May 26, 2023May 26, 2023 Pharmaceutical Industry Editor
kit for measuring plasma protein binding
Comments & Analysis Drug Discovery Latest Preclinical Studies R&D Sponsored 

Measuring Plasma Protein Binding: The Key to Unlocking Drug Efficacy and Safety

April 10, 2023April 24, 2023 Pharmaceutical Industry Editor
decorative
Comments & Analysis Digitalization Latest 

Personalised Medicine and AI: Transforming the Pharmaceutical Industry

March 28, 2023March 29, 2023 Pharmaceutical Industry Editor
Machine Learning Tissue Classifiers Power AI in Clinical Research
Clinical Trials Comments & Analysis Digitalization R&D Sponsored 

Machine Learning Tissue Classifiers Power AI in Clinical Research

March 6, 2023May 17, 2023 Pharmaceutical Industry Editor

RESOURCES

decorative
Downloads White Papers 

Nucleosides, Nucleotides & Nucleic Acids Toolbox – Free E-Book – Biosynth

September 16, 2023September 18, 2023 Pharmaceutical Industry Editor

Nucleosides, Nucleotides & Nucleic Acids Toolbox A Biosynth .pdf E-Book Part 1 – Nucleosides and Nucleotides Chemistry, Structures, Modifications Analysis,

decorative
Downloads White Papers 

Polysaccharides Toolbox – Free E-Book – Biosynth

September 3, 2023September 3, 2023 Pharmaceutical Industry Editor
decorative
Downloads White Papers 

Oligosaccharides Toolbox – Free E-Book – Biosynth

August 31, 2023August 31, 2023 Pharmaceutical Industry Editor
decorative
Downloads White Papers 

Cytostatic Isolator for Advanced Operator Safety and Cytotoxic Drug Manipulation

July 25, 2023September 24, 2023 Pharmaceutical Industry Editor
decorative
Downloads Manufacturing White Papers 

BLOCK Technology: Isolator Technology Product List 2023

July 18, 2023July 18, 2023 Pharmaceutical Industry Editor

MANUFACTURING PROJECTS

decorative
Drug Development Latest Manufacturing Projects 

Manufacturing Pharmaceuticals In Space

June 21, 2023September 19, 2023 Pharmaceutical Industry Editor

Varda Space Industries, a California-based startup, is venturing into the realm of pharmaceutical manufacturing in microgravity with the goal of

decorative
Manufacturing Projects 

Plasma-Derived Therapies Manufacturing Plant, 2030, Takeda, Osaka, Japan

March 27, 2023March 27, 2023 Pharmaceutical Industry Editor
WuXi STA Continuous Manufacturing Line for Oral Solids
Manufacturing Projects 

Continuous Manufacturing Line for Oral Solids,  WuXi STA, China

February 23, 2023September 19, 2023 Pharmaceutical Industry Editor
decorative
Manufacturing Projects 

BioNTech Boosts Autonomy with In-House Plasmid DNA Manufacturing Facility in Marburg

February 16, 2023March 4, 2023 Pharmaceutical Industry Editor
Plasmid DNA Manufacturing Facility, Catalent, Gosselies, Belgium
Manufacturing Projects 

Plasmid DNA Manufacturing Facility, Catalent, Gosselies, Belgium

January 31, 2023February 1, 2023 Pharmaceutical Industry Editor

CLINICAL TRIALS

decorative
Clinical Trials Immunology Inflammatory Diseases 

AstraZeneca’s Fasenra Achieves Primary Objective in Phase III Trial in EGPA

September 17, 2023September 17, 2023 Pharmaceutical Industry Editor

The MANDARA Phase III trial marks the first head-to-head comparison of biologics in treating eosinophilic granulomatosis with polyangiitis (EGPA), putting

decorative
Clinical Trials Drug Development Immunology Latest Neurology 

Coya Therapeutics’ COYA 301 (interleukin-2) Shows Promising Results in Open Label Alzheimer’s Study

May 17, 2023May 17, 2023 Pharmaceutical Industry Editor
decorative
Clinical Trials Latest Rare Diseases Respiratory 

ReCode Starts Phase 1 Trial of Inhaled Genetic Medicine for PCD

March 27, 2023March 29, 2023 Pharmaceutical Industry Editor
Machine Learning Tissue Classifiers Power AI in Clinical Research
Clinical Trials Comments & Analysis Digitalization R&D Sponsored 

Machine Learning Tissue Classifiers Power AI in Clinical Research

March 6, 2023May 17, 2023 Pharmaceutical Industry Editor
decorative
Clinical Trials Immunology Infectious Diseases 

Pfizer and BioNTech Start Phase 1/2 Study of First mRNA-based Shingles Vaccine in the US

February 13, 2023February 13, 2023 Pharmaceutical Industry Editor

REGULATORY

decorative
COVID-19 Infectious Diseases Latest Regulatory 

Pfizer and BioNTech Granted Favorable CHMP Assessment for Omicron XBB.1.5-adapted COVID-19 Vaccine in the EU

September 11, 2023September 17, 2023 Pharmaceutical Industry Editor

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommendation is grounded in pre-clinical

FDA Greenlights First-ever Treatment for Demodex Blepharitis
Latest Regulatory 

FDA Greenlights First-ever Treatment for Demodex Blepharitis

July 27, 2023July 27, 2023 Pharmaceutical Industry Editor
Complying with Mandates for Manufacture of Sterile Products
Regulatory Sponsored 

Complying with Mandates for Manufacture of Sterile Products

June 26, 2023June 26, 2023 Pharmaceutical Industry Editor
FDA Approves Krystal Biotech’s VYJUVEK™: First Redosable Skin-disorder Gene Therapy
DISEASES Latest Rare Diseases Regulatory 

FDA Approves Krystal Biotech’s VYJUVEK™: First Redosable Skin-disorder Gene Therapy

May 21, 2023May 23, 2023 Pharmaceutical Industry Editor
Astellas Pharma’s Pill for Menopause Hot Flashes Approved by the US FDA
Regulatory 

Astellas Pharma’s Pill for Menopause Hot Flashes Approved by the US FDA

May 14, 2023May 14, 2023 Pharmaceutical Industry Editor

SELECTED PRODUCTS

Immunohistochemistry analysis using STAT6 (Phospho-Tyr641) Antibody.
Products R&D 

Stat6 (Phospho-Tyr641) Antibody

September 20, 2023September 24, 2023 Pharmaceutical Industry Editor

The Stat6 (Phospho-Tyr641) Antibody from Assay Biotechnology is a polyclonal antibody that specifically recognizes the phosphorylated form of Stat6 at

Adjuvant for monoclonal antibody production
Preclinical Studies Products R&D 

High Yield Adjuvant for Monoclonal Antibody Production

September 17, 2023September 24, 2023 Pharmaceutical Industry Editor
Enzyme Engineering and Manufacturing Solutions
Manufacturing Products Services 

Enzyme Engineering and Manufacturing Solutions

September 13, 2023September 23, 2023 Pharmaceutical Industry Editor
Akt (Phospho-Thr308) Antibody
Products R&D 

Akt (Phospho-Thr308) Antibody

September 11, 2023September 24, 2023 Pharmaceutical Industry Editor
Conjugated Secondary Antibodies
Products R&D 

Conjugated Secondary Antibodies

September 7, 2023September 24, 2023 Pharmaceutical Industry Editor
Ticker Tape by TradingView

DON’T MISS A THING

Be the first to receive the latest news from the pharmaceutical industry

We don’t spam! Read our Privacy Policy for more info

Check your inbox or spam folder to confirm your subscription.

Advertisement

Featured Company

  • FEATURED
    • BLOCK Isolator Technology Logo 768x576

    BLOCK Technology

    Featured
    Category: Laboratory Equipment and Manufacturing Equipment
    Pharmaceutical Isolators, Containment and Aseptic Solutions Details Products Downloads Videos Press Releases Contact Details BLOCK Technology is a leading manufacturer of pharmaceutical isolators for containment or aseptic applications.The company offers an extensive selection of top-tier standard and custom containment isolators designed to ensure both flexibility and safety in the handling of hazardous materials. BLOCK also offers a range of clean Read more…

Featured Product

Immunohistochemistry analysis using STAT6 (Phospho-Tyr641) Antibody.
Products R&D 

Stat6 (Phospho-Tyr641) Antibody

September 20, 2023September 24, 2023 Pharmaceutical Industry Editor

The Stat6 (Phospho-Tyr641) Antibody from Assay Biotechnology is a polyclonal antibody that specifically recognizes the phosphorylated form of Stat6 at

LATEST

Develop New Targeting Vector for Radioligand Therapies
DISEASES Drug Discovery Latest Oncology 

Orano Med Partners with Biosynth to Develop New Targeting Vector for Radioligand Therapies

September 23, 2023September 24, 2023 Pharmaceutical Industry Editor

Orano Med, a clinical-stage biotechnology company that develops the next generation of targeted therapies against cancer using the unique properties

decorative
Deals Latest 

PeptiDream and Genentech Ink $1 Billion Deal for Peptide-RI Drug Conjugates

September 21, 2023September 21, 2023 Pharmaceutical Industry Editor
Immunohistochemistry analysis using STAT6 (Phospho-Tyr641) Antibody.
Products R&D 

Stat6 (Phospho-Tyr641) Antibody

September 20, 2023September 24, 2023 Pharmaceutical Industry Editor
Adjuvant for monoclonal antibody production
Preclinical Studies Products R&D 

High Yield Adjuvant for Monoclonal Antibody Production

September 17, 2023September 24, 2023 Pharmaceutical Industry Editor
decorative
Clinical Trials Immunology Inflammatory Diseases 

AstraZeneca’s Fasenra Achieves Primary Objective in Phase III Trial in EGPA

September 17, 2023September 17, 2023 Pharmaceutical Industry Editor
decorative
Downloads White Papers 

Nucleosides, Nucleotides & Nucleic Acids Toolbox – Free E-Book – Biosynth

September 16, 2023September 18, 2023 Pharmaceutical Industry Editor
Enzyme Engineering and Manufacturing Solutions
Manufacturing Products Services 

Enzyme Engineering and Manufacturing Solutions

September 13, 2023September 23, 2023 Pharmaceutical Industry Editor
Akt (Phospho-Thr308) Antibody
Products R&D 

Akt (Phospho-Thr308) Antibody

September 11, 2023September 24, 2023 Pharmaceutical Industry Editor
decorative
Deals DISEASES Featured Immunology Inflammatory Diseases 

Sandoz Strengthens Immunology Portfolio with Samsung Bioepis Deal to Commercialize Biosimilar Ustekinumab

September 11, 2023September 11, 2023 Pharmaceutical Industry Editor
decorative
COVID-19 Infectious Diseases Latest Regulatory 

Pfizer and BioNTech Granted Favorable CHMP Assessment for Omicron XBB.1.5-adapted COVID-19 Vaccine in the EU

September 11, 2023September 17, 2023 Pharmaceutical Industry Editor
Conjugated Secondary Antibodies
Products R&D 

Conjugated Secondary Antibodies

September 7, 2023September 24, 2023 Pharmaceutical Industry Editor
Continuous Liner for a Cleanroom Partition
Products R&D 

Continuous Liner for a Cleanroom Partition

September 5, 2023September 11, 2023 Pharmaceutical Industry Editor
VHP Decontamination Lock
Products R&D 

VHP Decontamination Lock

September 5, 2023September 5, 2023 Pharmaceutical Industry Editor
Mobile Hydrogen Peroxide Vapour Generator
Products R&D 

Mobile Hydrogen Peroxide Vapour Generator – Puriter

September 5, 2023September 5, 2023 Pharmaceutical Industry Editor
Aalto Bio Reagents and Fitzgerald Industries International Rebrand to Biosynth
Press Releases 

Aalto Bio Reagents and Fitzgerald Industries International Rebrand to Biosynth

September 3, 2023September 3, 2023 Pharmaceutical Industry Editor
decorative
Downloads White Papers 

Polysaccharides Toolbox – Free E-Book – Biosynth

September 3, 2023September 3, 2023 Pharmaceutical Industry Editor
COL1A2 Antibody
Products R&D 

COL1A2 Antibody

September 2, 2023September 24, 2023 Pharmaceutical Industry Editor
decorative
Downloads White Papers 

Oligosaccharides Toolbox – Free E-Book – Biosynth

August 31, 2023August 31, 2023 Pharmaceutical Industry Editor

About Us

Logo
Pharma Industry Review is here to provide you with the latest news, reviews and insights from the pharmaceutical industry so that you can take your business one step ahead.

About Us

  • Contact Us
  • Editorial Standards
  • Terms & Conditions
  • Privacy Policy
  • Users

Useful Links

  • Client Portal
  • Advertise
  • Presentation Portal
  • Sectors
  • Projects
  • RSS Feed

RSS Feed

Copyright © 2023 Pharma Industry Review. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits, according to our Privacy Policy. You can enable the specific cookies from Settings or consent to the use of ALL the cookies.
.
Cookie settingsACCEPT ALL
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
__hssc30 minutesThis cookie is set by HubSpot. The purpose of the cookie is to keep track of sessions. This is used to determine if HubSpot should increment the session number and timestamps in the __hstc cookie. It contains the domain, viewCount (increments each pageView in a session), and session start timestamp.
na_id1 year 1 monthThis cookie is set by Addthis.com to enable sharing of links on social media platforms like Facebook and Twitter
na_rn1 monthThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_sc_e1 monthThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_sr1 monthThis cookie is set by Addthis.com. This cookie is used for sharing of links on social media platforms.
na_srp1 minuteThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_tc1 year 1 monthThis cookie is set by the provider Addthis. This cookie is used for social media sharing tracking service.
ouid1 year 1 monthThe cookie is set by Addthis which enables the content of the website to be shared across different networking and social sharing websites.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
d3 monthsThis cookie tracks anonymous information on how visitors use the website.
YSCsessionThis cookies is set by Youtube and is used to track the views of embedded videos.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
__gads1 year 24 daysThis cookie is set by Google and stored under the name dounleclick.com. This cookie is used to track how many times users see a particular advert which helps in measuring the success of the campaign and calculate the revenue generated by the campaign. These cookies can only be read from the domain that it is set on so it will not track any data while browsing through another sites.
__hstc1 year 24 daysThis cookie is set by Hubspot and is used for tracking visitors. It contains the domain, utk, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_149839117_11 minuteGoogle uses this cookie to distinguish users.
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information on how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
hubspotutk1 year 24 daysThis cookie is used by HubSpot to keep track of the visitors to the website. This cookie is passed to Hubspot on form submission and used when deduplicating contacts.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
ab1 yearThis domain of this cookie is owned by agkn. The cookie is used for targeting and advertising purposes.
CMID1 yearThe cookie is set by CasaleMedia. The cookie is used to collect information about the usage behavior for targeted advertising.
CMPRO3 monthsThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMPS3 monthsThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMRUM31 yearThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMST1 dayThe cookie is set by CasaleMedia. The cookie is used to collect information about the usage behavior for targeted advertising.
DSID1 hourThis cookie is setup by doubleclick.net. This cookie is used by Google to make advertising more engaging to users and are stored under doubleclick.net. It contains an encrypted unique ID.
id1 year 1 monthThe main purpose of this cookie is targeting and advertising. It is used to create a profile of the user's interest and to show relevant ads on their site. This Cookie is set by DoubleClick which is owned by Google.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
KADUSERCOOKIE3 monthsThe cookie is set by pubmatic.com for identifying the visitors' website or device from which they visit PubMatic's partners' website.
KTPCACOOKIE1 dayThis cookie is set by pubmatic.com for the purpose of checking if third-party cookies are enabled on the user's website.
mc1 year 1 monthThis cookie is associated with Quantserve to track anonymously how a user interact with the website.
mdata1 year 1 monthThe domain of this cookie is owned by Media Innovation group. This cookie registers a unique ID used to identify a visitor on their revisit inorder to serve them targeted ads.
ov1 year 1 monthThis cookie is set by the provider mookie1.com. This cookie is used for serving the user with relevant content and advertisement.
pxrc2 monthsThe purpose of the cookie is to identify a visitor to serve relevant advertisement.
rlas31 yearThe cookie is set by rlcdn.com. The cookie is used to serve relevant ads to the visitor as well as limit the time the visitor sees an and also measure the effectiveness of the campaign.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
uid1 year 1 monthThis cookie is used to measure the number and behavior of the visitors to the website anonymously. The data includes the number of visits, average duration of the visit on the website, pages visited, etc. for the purpose of better understanding user preferences for targeted advertisments.
uuid3 monthsTo optimize ad relevance by collecting visitor data from multiple websites such as what pages have been loaded.
uuid23 monthsThis cookies is set by AppNexus. The cookies stores information that helps in distinguishing between devices and browsers. This information us used to select advertisements served by the platform and assess the performance of the advertisement and attribute payment for those advertisements.
VISITOR_INFO1_LIVE5 months 27 daysThis cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
anj3 monthsNo description
CONSENT16 years 9 months 12 days 8 hoursNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
GoogleAdServingTestsessionNo description
i1 yearThe purpose of the cookie is not known yet.
u1 yearThe purpose of this cookie is targeting and marketing.The domain of this cookie is related with a company called Bombora in USA.
SAVE & ACCEPT
Powered by CookieYes Logo